Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience.

Ganzel, Chezi; Sun, Zhuoxin; Cripe, Larry D; Fernandez, Hugo F; Douer, Dan; Rowe, Jacob M; Paietta, Elisabeth M; Ketterling, Rhett; O'Connell, Michael J; Wiernik, Peter H; Bennett, John M; Litzow, Mark R; Luger, Selina M; Lazarus, Hillard M; Tallman, Martin S.
Am J Hematol; 2018 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-29905379

Não foram localizados documentos relacionados